Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds
Authors:
- Joseph M. CostelloJCJoseph M. Costello
- Vincenzo CardinaleVCVincenzo Cardinale
- Domenico AlvaroDADomenico Alvaro
Open Access
- 24 September 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 53 (1) , 293-305
Abstract
Current protocols for differentiation of stem cells make use of multiple treatments of soluble signals and/or matrix factors and result typically in partial differentiation to mature cells with under- or overexpression of adult tissue-specific genes. We developed a strategy for rapid and efficient differentiation of stem cells using substrata of biomatrix scaffolds, tissue-specific extracts enriched in extracellular matrix, and associated growth factors and cytokines, in combination with a serum-free, hormonally defined medium (HDM) tailored for the adult cell type of interest. Biomatrix scaffolds were prepared by a novel, four-step perfusion decellularization protocol using conditions designed to keep all collagen types insoluble. The scaffolds maintained native histology, patent vasculatures, and ≈1% of the tissue's proteins but >95% of its collagens, most of the tissue's collagen-associated matrix components, and physiological levels of matrix-bound growth factors and cytokines. Collagens increased from almost undetectable levels to >15% of the scaffold's proteins with the remainder including laminins, fibronectins, elastin, nidogen/entactin, proteoglycans, and matrix-bound cytokines and growth factors in patterns that correlate with histology. Human hepatic stem cells (hHpSCs), seeded onto liver biomatrix scaffolds and in an HDM tailored for adult liver cells, lost stem cell markers and differentiated to mature, functional parenchymal cells in ≈1 week, remaining viable and with stable mature cell phenotypes for more than 8 weeks. Conclusion: Biomatrix scaffolds can be used for biological and pharmaceutical studies of lineage-restricted stem cells, for maintenance of mature cells, and, in the future, for implantable, vascularized engineered tissues or organs. (Hepatology 2011.)Keywords
This publication has 48 references indexed in Scilit:
- Paracrine Signals from Mesenchymal Cell Populations Govern the Expansion and Differentiation of Human Hepatic Stem Cells to Adult Liver FatesHepatology, 2010
- Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrixNature Medicine, 2010
- Efficient generation of hepatocyte-like cells from human induced pluripotent stem cellsCell Research, 2009
- In Vitro Differentiation of Embryonic and Adult Stem Cells into Hepatocytes: State of the ArtStem Cells, 2009
- Collagen fiber alignment and biaxial mechanical behavior of porcine urinary bladder derived extracellular matrixBiomaterials, 2008
- The stem cell niche of human livers: Symmetry between development and regenerationHepatology, 2008
- Native Umbilical Cord Matrix Stem Cells Express Hepatic Markers and Differentiate Into Hepatocyte-like CellsGastroenterology, 2008
- Chondroitin Sulfate Sulfation Motifs as Putative Biomarkers for Isolation of Articular Cartilage Progenitor CellsJournal of Histochemistry & Cytochemistry, 2007
- Human hepatic stem cells from fetal and postnatal donorsJournal of Experimental Medicine, 2007
- Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cellsNature Biotechnology, 2006